ID

16056

Description

Documentation part: Status of Treatment Bling & Study Conclusion A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Mots-clés

Versions (1)
  1. 27/06/2016 27/06/2016 -
Téléchargé le

27 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Anglais

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulaires  
Status of Treatment Blind (BLIND)
Description

Status of Treatment Blind (BLIND)

Was the treatment blind broken during the study?
Description

If yes, complete the Adverse Event form and/or Investigational Product forms as appropriate

Type de données

text

Alias
UMLS CUI [1]
C2347038
Date blind broken
Description

Date blind broken

Type de données

date

Unités de mesure
  • DDMONYYYY
Alias
UMLS CUI [1]
C0011008
DDMONYYYY
Reason blind broken
Description

Reason blind broken

Type de données

text

Alias
UMLS CUI [1]
C0392360
If "Other", please specify:
Description

If

Type de données

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Study Conclusion (CONC)
Description

Study Conclusion (CONC)

Date of subject completion or date of subject withdrawal
Description

Date of subject completion or date of subject withdrawal

Type de données

date

Alias
UMLS CUI [1]
C2983670
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0422727
Was the subject withdrawn from the study?
Description

Was the subject withdrawn from the study?

Type de données

text

Alias
UMLS CUI [1]
C0422727
If "Yes", select primary reason for withdrawal
Description

If "Yes", select primary reason for withdrawal

Type de données

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0422727
If "other", specify:
Description

If "other", specify:

Type de données

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Retour au début de la page

Similar models

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Status of Treatment Blind (BLIND)
Item
Was the treatment blind broken during the study?
text
C2347038 (UMLS CUI [1])
Was the treatment blind broken during the study?
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes (Y)
Date blind broken
Item
Date blind broken
date
C0011008 (UMLS CUI [1])
Item
Reason blind broken
text
C0392360 (UMLS CUI [1])
Reason blind broken
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other (2)
If
Item
If "Other", please specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Study Conclusion (CONC)
Date of subject completion or date of subject withdrawal
Item
Date of subject completion or date of subject withdrawal
date
C2983670 (UMLS CUI [1])
C0011008 (UMLS CUI [2,1])
C0422727 (UMLS CUI [2,2])
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Was the subject withdrawn from the study?
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
If "Yes", select primary reason for withdrawal
text
C0392360 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
If "Yes", select primary reason for withdrawal
Code List
If "Yes", select primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Disease progression (7)
CL Item
Other (OT)
If "other", specify:
Item
If "other", specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial